Many respiratory viruses cause us to temporarily lose our sense of smell. But SARS-CoV-2 isn’t like those other viruses. Researchers are now exploring how it differs and whether patients recover.
Scanning through billions of chemicals to find a few potential drugs for treating COVID-19 requires computers that harness together thousands of processors.
Drugs and vaccines to fight the coronavirus are already in clinical trials. It is important to understand the difference between each step in this process as efforts to fight COVID-19 continue.
Joshua Aizenman, USC Dornsife College of Letters, Arts and Sciences
Over the first 100 days of the pandemic, countries that quickly implemented strong policies successfully lowered their death rates faster. There were also some surprises in the successes and failures.
Thinking of SARS-CoV-2 as an invisible enemy with an evil personality and humanlike motivations is a natural offshoot of the way people evolved to anthropomorphize so as not to overlook threats.
We blame the coronavirus for the thousands of deaths, but it is actually a hyperactive immune reaction that is the cause of death. An immunologist explains.
Should I wear a mask and gloves in the grocery story? Sanitize my food? A food virologist takes on the top questions people are asking as they shop for food amid the coronavirus pandemic.
A CSIRO survey has found many people are confused about common infections, believing antibiotics can treat colds, flu and other viruses. This could fuel a dangerous rise in drug-resistant superbugs.
Finding drugs that treat the COVID-19 coronavirus may be just as important as developing a vaccine. But it’s much harder to create effective antivirals than antibiotics.
A biomedical researcher and pediatrician who works with Kawasaki disease and COVID-19 explains the similarities and differences in the worrisome cases doctors are starting to see.
Researchers from Oregon Health and Science University found that variations in genes that code for parts of the cellular alarm system might play a role in how well people fight off COVID-19.
Nevan Krogan, University of California, San Francisco
Researchers at the University of California, San Francisco, identified nine existing drugs that show promise to treat COVID-19. The proteins they target haven’t been tried before.
Who is most likely to survive an infection of the new coronavirus? Two immunologists explain that it is those who mount exactly the right immune response – not too weak, not too strong.
Director, The Peter Doherty Institute for Infection and Immunity, The University of Melbourne and Royal Melbourne Hospital and Consultant Physician, Department of Infectious Diseases, Alfred Hospital and Monash University, The Peter Doherty Institute for Infection and Immunity